Screener
Agios Pharmaceuticals AGIO Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.21B.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's market capitalization?
- Agios Pharmaceuticals (AGIO) reported market capitalization of $2.21B in Q2 2026.
- How has Agios Pharmaceuticals's market capitalization changed year-over-year?
- Agios Pharmaceuticals's market capitalization increased by 14.0% year-over-year, from $1.94B to $2.21B.
- What is the long-term trend for Agios Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's market capitalization has grown at a -7.6% compound annual growth rate (CAGR), from $2.35B to $1.59B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Agios Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude